SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
75.50    0.00 (0.00%)
Bid:
73.00
Ask:
78.00
Spread: 5.00 (6.849%)
Market Cap: £10.10m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Preliminary Results

3 Aug 2012 07:00

RNS Number : 2143J
Arcontech Group PLC
03 August 2012
Β 

ο»Ώ

ARCONTECH GROUP PLC

Β 

("Arcontech" or the "Company")

Β 

PRELIMINARY RESULTS FOR THE YEAR ENDED 30 JUNE 2012

Β 

Arcontech Group plc (AIM: ARC), a provider of enterprise level real-time software solutions to the investment banking and broking sectors, reports its preliminary results for the year ended 30 June 2012.

Β 

Chairman's Statement

Β 

Arcontech Group plc has achieved notable progress during the year ended 30 June 2012. The business is now focused on the CityVision suite of software products with particular emphasis on Multi Vendor Contribution Systems ("MVCS"), Excelerator, our real time Excel product and CityVision Cache.

Β 

We believe that the opportunities for our products are at a level not previously experienced by the group. We do, however, have to convert these opportunities into sales. Whilst this has proved a little frustrating, with decision-making and proof of concept trials taking longer, we have secured new contracts of almost Β£1 million over three years. As at 30 June 2012 the contracted annual recurring licence fees amounted to Β£1,589,110 (2011: Β£1,538,216) representing approximately 76% of our annual costs (2011: 73%).

Β 

Turnover for the year increased by 14% to Β£1,463,530 (2011: Β£1,287,409). The underlying increase was 28% after eliminating revenue from the loss-making AXE product, which we stopped actively marketing during the year. The operating loss for the year was Β£595,147 (2011: Β£817,855). During the year we continued to invest significantly in product development and improvement. These costs are written off as they are incurred.

Β 

Financing

Β 

As at 30 June 2012 Arcontech had cash balances of Β£746,675 (2011: Β£841,204). The reduction in our cash resources is due to the operating loss incurred during the year, arising primarily due to our continued investment in product development together with lengthening payment periods from clients. Based upon the level of our sales prospects and our continued tight control of costs the Board believes that Arcontech has sufficient financial resources to see the business through to profitability.

Β 

Employees

Β 

As in previous years I should like to thank our employees for their continued hard work, dedication and support over the last twelve months. Working in a small business often requires employees to be extremely flexible and understanding, this is greatly appreciated.

Β 

Outlook

Β 

With the level of sales prospects that Arcontech presently has we are hopeful of making significant progress towards breakeven in the coming year. It remains, however, difficult to determine the precise timing of future contracts, as sales cycles remain protracted. To help improve our chances of success we are looking to increase our sales resource in the coming months.

Β 

Richard Last

Chairman

Β 

2 August 2012

Β 

Β 

Chief Executive's Review

Β 

I am pleased with the progress made this year with theΒ enhancement and rationalisation of the CityVision product suite. CityVision now addresses several areas of current demand in a more appropriate and immediately deployable manner and we are seeing strong interest, evidenced by increased sales, from both new and existing clients.

Β 

The uptake of the redesigned 'Excelerator' product, which provides a vendor-neutral means of publishing and receiving real-time market data into Microsoft Excel, has increased significantly. Excelerator's ability to integrate with, and provide a migration path between,Β Thomson Reuters and Bloomberg is a compelling value proposition amongst investment banks eager to reduce costs and reduce lock-in to particular vendors.

Β 

CityVision Cache, a new product development this year, gives customers increased choice of technology and is also attracting strong interest, with recent new sales.

Β 

New contracts have been longer in negotiation than I would have liked, impairing our revenue growth. Nonetheless, the number of ongoing and successful product evaluations and prospects at or close to contract stage support optimism over forward revenues.

Β 

Interest from outside the UK and, in particular, new sales activity in the Nordic regions continues and we have seen several of the new contracts anticipated in last year's review. We have further refined our offerings for integration with Thomson Reuters and Bloomberg and the new product developments mentioned last year are now deployed with Tier 1 and Tier 2 investments banks, facilitating considerable cost reductions and future flexibility.

Β 

Increased sales and marketing activity, resulting in significant product interest, has demanded additional pre and post sales resource to support trials and product roll-out. We have recruited in response to this demand and our expanded, experienced support team is well equipped to deal with forecast new business.

Β 

Some notable points for the year have been:

Β 

Β·; Successful live deployment of CityVision in multiple regions

Β·; New contracts for Excelerator, MVCS and CityVision Cache

Β·; Upgrade of several clients to the enhanced product set

Β·; 100% retention of existing CityVision clients

Β·; Increase in contracted recurring revenues of approximately Β£1 million

Β 

Our status as an independent software supplier, with two-way interfaces between the popular vendors, positions us well to take advantage of the prevailing demand for customer choice of data vendor and delivery technology.

Β 

I would like to thank the board, our staff and particularly our new and existing clients for their continued support and look forward to further successes in the coming year.

Β 

Andrew Miller

Chief Executive

Β 

Β 

Enquiries:

Β 

Arcontech Group plc

Β 

Andrew Miller, Chief Executive

Β 

Sarah Wisbey

+44 20 7256 2300

Β 

Β 

Northland Capital Partners Limited

Β 

Shane Gallwey

+44 20 7796 8823

Β 

Β 

Group Income Statement

Β 

For the year ended 30 June 2012

Β 

Β 

Β 

2012

Β 

2011

Β 

Β£

Β 

Β£

Β 

Β 

Β 

Β 

Revenue

1,463,530

Β 

1,287,409

Β 

Β 

Β 

Β 

Distribution costs

(19,477)

Β 

(16,428)

Β 

Β 

Β 

Β 

Administrative costs

(2,039,200)

Β 

(2,088,836)

Β 

Operating loss

(595,147)

Β 

(817,855)

Β 

Β 

Β 

Β 

Finance income

8,756

Β 

13,134

Β 

Loss before taxation

(586,391)

Β 

(804,721)

Β 

Β 

Β 

Β 

Taxation

85,319

Β 

132,683

Β 

Loss for the year after tax

(501,072)

Β 

(672,038)

Β 

Total comprehensive income

(501,072)

Β 

(672,038)

Β 

Loss per share (basic and diluted)

(0.03)p

Β 

(0.04)p

Β 

All of the results relate to continuing operations.

Β 

Β 

Statement of Changes in Equity

Β 

For the year ended 30 June 2012

Β 

Group:

Β 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Total

equity

Β 

Β£

Β£

Β£

Β£

Β£

Balance at 1 July 2010

1,531,315

9,428,169

143,297

(8,300,747)

2,802,034

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the year

-

-

-

(672,038)

(672,038)

Β 

Total comprehensive income for the year

-

-

-

(672,038)

(672,038)

Β 

Β 

Β 

Β 

Β 

Β 

Share-based payments

-

-

2,241

-

2,241

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 June 2011

1,531,315

9,428,169

145,538

(8,972,785)

2,132,237

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the year

-

-

-

(501,072)

(501,072)

Β 

Total comprehensive income for the year

-

-

-

(501,072)

(501,072)

Β 

Β 

Β 

Β 

Β 

Β 

Share-based payments

-

-

45,222

-

45,222

Β 

Balance at 30 June 2012

1,531,315

9,428,169

190,760

(9,473,857)

1,676,387

Β 

Company:

Β 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Total

equity

Β 

Β£

Β£

Β£

Β£

Β£

Balance at 1 July 2010

1,531,315

9,428,169

143,297

(7,447,378)

3,655,403

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the year

-

-

-

(82,460)

(82,460)

Β 

Total comprehensive income for the year

-

-

-

(82,460)

(82,460)

Β 

Β 

Β 

Β 

Β 

Β 

Share-based payments

-

-

2,241

-

2,241

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 June 2011

1,531,315

9,428,169

145,538

(7,529,838)

3,575,184

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the year

-

-

-

(35,850)

(35,850)

Β 

Total comprehensive income for the year

-

-

-

(35,850)

(35,850)

Β 

Β 

Β 

Β 

Β 

Β 

Share-based payments

-

-

45,222

-

45,222

Β 

Balance at 30 June 2012

1,531,315

9,428,169

190,760

(7,565,688)

3,584,556

Β 

Β 

Balance Sheets

Β 

As at 30 June 2012

Β 

Β 

Group2012Β£

Β 

Group2011Β£

Β 

Company2012Β£

Β 

Company2011

Β£

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Non-current assets

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Goodwill

1,715,153

Β 

1,715,153

Β 

-

Β 

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Property, plant and equipment

34,263

Β 

37,426

Β 

-

Β 

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Investments in subsidiaries

-

Β 

-

Β 

2,017,373

Β 

2,017,373

Total non-current assets

1,749,416

Β 

1,752,579

Β 

2,017,373

Β 

2,017,373

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other receivables

667,637

Β 

366,425

Β 

1,845,027

Β 

1,450,431

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents

746,675

Β 

841,204

Β 

37,595

Β 

471,172

Total current assets

1,414,312

Β 

1,207,629

Β 

1,882,622

Β 

1,921,603

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current liabilities

Trade and other payables

(1,487,341)

(827,971)

(315,439)

(363,792)

Total current liabilities

(1,487,341)

(827,971)

(315,439)

(363,792)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net current (liabilities)/assets

(73,030)

Β 

379,658

Β 

1,567,183

Β 

1,557,811

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net assets

1,676,387

Β 

2,132,237

Β 

3,584,556

Β 

3,575,184

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Called up share capital

1,531,315

Β 

1,531,315

Β 

1,531,315

Β 

1,531,315

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share premium account

9,428,169

Β 

9,428,169

Β 

9,428,169

Β 

9,428,169

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share option reserve

190,760

Β 

145,538

Β 

190,760

Β 

145,538

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Retained earnings

(9,473,857)

Β 

(8,972,785)

Β 

(7,565,688)

Β 

(7,529,838)

Β 

1,676,387

2,132,237

Β 

3,584,556

Β 

3,575,184

Β 

Group Cash Flow Statement

Β 

For the year ended 30 June 2012

Β 

Β 

2012

Β 

2011

Β 

Β 

Β£

Β 

Β£

Β 

Β 

Β 

Β 

Β 

Β 

Net cash used in operating activities

(90,351)

Β 

(747,493)

Β 

Β 

Investing activities

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Interest received

8,756

Β 

13,134

Β 

Β 

Β 

Β 

Β 

Β 

Purchases of plant and equipment

(12,934)

Β 

(11,214)

Β 

Β 

Β 

Β 

Β 

Β 

Disposal of plant and equipment

-

Β 

401

Β 

Β 

Net cash (used)/received in investing activities

(4,178)

Β 

2,321

Β 

Β 

Net decrease in cash and cash equivalents

(94,529)

Β 

(745,172)

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at beginning of year

841,204

Β 

1,586,376

Β 

Β 

Cash and cash equivalents at end of year

746,675

Β 

841,204

Β 

Β 

Β 

Company Cash Flow Statement

Β 

For the year ended 30 June 2012

Β 

Β 

2012

Β 

2011

Β 

Β 

Β£

Β 

Β£

Β 

Β 

Net cash used in operating activities

(435,926)

Β 

(395,785)

Β 

Β 

Investing activities

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Interest received

2,349

Β 

7,579

Β 

Β 

Net cash generated from investing activities

2,349

Β 

7,579

Β 

Β 

Net decrease in cash and cash equivalents

(433,577)

Β 

(388,206)

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at beginning of year

471,172

Β 

859,378

Β 

Β 

Cash and cash equivalents at end of year

37,595

Β 

471,172

Β 

Β 

Β 

Notes to the Financial Statements

Β 

For the year ended 30 June 2012

Β 

1. Accounting policies

Β 

TheΒ principalΒ accountingΒ policiesΒ areΒ summarisedΒ below. TheyΒ haveΒ allΒ beenΒ applied consistently throughout the period covered bytheseΒ financial statements.

Β 

Reporting entity

Β 

Arcontech Group PLC ("the Company") is a company incorporated in the United Kingdom. The consolidated financial statements incorporate the financial statements of the Company and its subsidiaries (together referred to as "the Group").

Β 

Basis ofpreparation

Β 

These financial statements haveΒ beenΒ preparedΒ inΒ accordanceΒ withΒ InternationalΒ Financial Reporting Standards ("IFRS") endorsed by the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

Β 

On the basis of current projections, confidence of future profitability and cash balances held, the Directors have adopted the going concern basis in the preparation of the financialΒ statements.

Β 

TheΒ financialΒ statementsΒ haveΒ beenΒ preparedΒ underΒ theΒ historical costΒ convention.

Β 

2. Revenue

Β 

An analysis of the Group's revenue is as follows:

Β 

Β 

Β 

2012Β£

Β 

2011Β£

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Financial information service, advertising and sponsorship, software development and consultancy

Β 

1,463,530

Β 

1,287,409

Β 

Β 

All of the Group's revenue relates to continuing activities.

Β 

3. Operating loss for the year is stated after charging:

Β 

Β 

Β 

2012Β£

Β 

2011Β£

Β 

Depreciation of plant and equipment

Β 

15,552

Β 

16,893

Β 

Loss on disposal of fixed assets

Β 

545

Β 

3,091

Β 

Staff costs (see note 7)

Β 

1,408,153

Β 

1,473,442

Β 

Operating lease rentals - land and buildings (see note 21)

Β 

79,000

Β 

73,075

Β 

Research and development

Β 

669,400

Β 

812,559

Β 

Β 

Β 

4. Loss per share

Β 

Β 

Β 

2012

Β 

2011

Β 

Β 

Β 

Β£

Β 

Β£

Β 

Earnings

Β 

Β 

Β 

Β 

Β 

Earnings for the purpose of basic and diluted earnings per share being net loss attributable to equity shareholders

Β 

(501,072)

Β 

(672,038)

Β 

Β 

Β 

(501,072)

Β 

(672,038)

Β 

Β 

Β 

Β 

No.

Β 

No.

Β 

Number of shares

Β 

Β 

Β 

Β 

Β 

Weighted average number of ordinary shares for the purpose of basic earnings per share

Β 

1,531,314,870

Β 

1,531,314,870

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Number of dilutive shares under option

Β 

-

Β 

-

Β 

Weighted average number of ordinary shares for the purposes of dilutive earnings per share

Β 

1,531,314,870

Β 

1,531,314,870

Β 

Β 

The calculation of diluted earningsΒ per share assumesΒ conversionΒ of all potentiallyΒ dilutive ordinary shares, allΒ of which arise fromΒ shareΒ options. A calculationΒ isΒ doneΒ toΒ determineΒ theΒ numberΒ ofΒ sharesΒ that couldΒ haveΒ been acquired at fair value, based uponΒ theΒ monetaryΒ value ofΒ theΒ subscription rightsΒ attachedΒ to outstandingΒ shareΒ options. Share options are anti-dilutive and are therefore not included above.

Β 

5. Dividends

Β 

There were no dividends paid or proposed during the period (2011: Β£Nil).

Β 

6. Post balance sheet events

Β 

There were no events since the balance sheet date, which materially affect the position of the Group.

Β 

7. Annual General Meeting

Β 

The annual general meeting of the Company will be held at the Company's offices 8th Floor, Finsbury Tower, 103-105 Bunhill Row, London EC1Y 8LZ on 23 October 2012 at 10 a.m.

Β 

8. Annual Report & Accounts

Β 

Copies of the Annual Report & Accounts will be sent to shareholders shortly and are available from the Company Secretary at the Company's registered office at 8th Floor Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8LZ or from the Company's website at www.arcontech.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR UGUWPRUPPGQP
Date   Source Headline
6th Feb 20263:02 pmRNSDirector/PDMR Shareholding
5th Feb 20265:35 pmRNSDirector/PDMR Shareholding
5th Feb 20263:08 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSInterim Results for the Six Months Ended 31 Dec 25
18th Dec 20251:42 pmRNSGrant of Options
18th Dec 20251:42 pmRNSGrant of Options
23rd Sep 20255:53 pmRNSPosting of Annual Report & Notice of AGM
10th Sep 20257:00 amRNSFinal Results for the year ended 30 June 2025
12th Aug 20257:00 amRNSTrading Update
14th Mar 20257:00 amRNS-RArcontech achieves ISO certifications
5th Mar 20254:26 pmRNSDirector/PDMR Shareholding
3rd Mar 20259:26 amPRNNet Asset Value(s)
26th Feb 20254:44 pmRNSDirector/PDMR Shareholding
26th Feb 20251:03 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSInterim Results
5th Dec 20245:45 pmRNSGrant of Options
11th Nov 20247:00 amRNSDirector/PDMR Shareholding
9th Oct 20243:53 pmRNSResult of AGM
17th Sep 20244:46 pmRNSPosting of Annual Report & Notice of AGM
2nd Sep 20247:00 amRNSFinal Results
22nd Jul 20247:00 amRNSTrading Update & Notice of Results
21st Feb 20247:00 amRNSInterim Results
27th Oct 20237:00 amRNSNew Client Win
25th Oct 20231:42 pmRNSResult of AGM
3rd Oct 20235:40 pmRNSPosting of Annual Report & Notice of AGM
5th Sep 20237:00 amRNSFinal Results
24th Jul 20237:00 amRNSTrading Update and Notice of Results
10th May 20237:00 amRNSAppointment of consultant in Singapore
6th Apr 202311:45 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector Retirement
27th Feb 20237:00 amRNSInterim Results
26th Oct 20223:15 pmRNSBoard Appointment
21st Oct 20227:00 amRNSGrant of Options
17th Oct 20222:41 pmRNSResult of AGM
17th Oct 20222:41 pmRNSResult of AGM
23rd Sep 20224:30 pmRNSPosting of Annual Report & Notice of AGM
12th Sep 20227:00 amRNSFinal Results
30th Aug 20227:00 amRNSNotice of Results
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSInterim Results
17th Jan 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20219:06 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSTrading Update
15th Oct 20215:32 pmRNSDirector/PDMR Shareholding
12th Oct 20215:00 pmRNSGrant of Options
11th Oct 20217:00 amRNSHolding(s) in Company
1st Oct 20213:30 pmRNSResult of AGM
8th Sep 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Sep 20217:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.